A patient post‑total hip arthroplasty with a possible wound infection under the pannus has completed 10 days of clindamycin 300 mg twice daily, has intermittent redness, and a sulfonamide allergy; should the antibiotic course be extended and what is the appropriate management?

Management of Post-Total Hip Arthroplasty Wound Infection

Continue clindamycin 300 mg twice daily for an additional 3-7 days while ensuring adequate wound assessment and local wound care, as the intermittent redness suggests incomplete resolution of a superficial surgical site infection.

Rationale for Extended Therapy

The IDSA guidelines for surgical site infections (SSI) indicate that a brief course of systemic antimicrobial therapy is indicated when erythema and induration extend >5 cm from the wound edge or when systemic signs are present (temperature >38.5°C, heart rate >110 beats/minute, or WBC count >12,000/µL) 1. Your patient's intermittent redness suggests ongoing inflammation that warrants continued treatment.

Key Decision Points

Assess the following immediately:

• Extent of erythema: Measure if redness extends >5 cm from wound margins
• Systemic signs: Check temperature, heart rate, and WBC count
• Wound characteristics: Look for purulent drainage, dehiscence, or fluctuance
• Timing: She is approximately 3-4 weeks post-surgery (10 days antibiotics + pre-treatment period)

Antibiotic Selection with Sulfa Allergy

Clindamycin is an appropriate choice for this patient given her sulfonamide allergy 2. The drug label confirms clindamycin is indicated for serious skin and soft tissue infections caused by susceptible staphylococci and streptococci, particularly in penicillin-allergic patients 2.

Alternative Options if Clindamycin Fails:

• First-generation cephalosporin (cefazolin or cefalexin) if no true penicillin allergy 1
• Vancomycin if MRSA risk factors present (recent hospitalization, prior MRSA, recent antibiotics) 1
• Doxycycline as secondary option 1

Critical Surgical Considerations

The pannus location is a major concern. Wounds under skin folds have:

• Increased moisture and maceration risk
• Higher bacterial colonization
• Impaired wound healing
• Greater risk of deep infection

Urgent surgical evaluation is needed if:

• Purulent drainage develops
• Erythema progresses despite antibiotics
• Systemic signs emerge
• Wound dehiscence occurs

The IDSA guidelines emphasize that suture removal plus incision and drainage should be performed for surgical site infections 1. The most important therapy for SSI is opening the incision and evacuating infected material 1.

Duration of Therapy

For superficial SSI without systemic signs:

• Total duration: 10-14 days is typically adequate 1
• She has completed 10 days, so 3-7 additional days is reasonable
• If systemic signs present: may need 24-48 hours of therapy after clinical improvement 1

Monitor closely during extended therapy:

• Daily wound inspection for first 3 days
• Temperature and vital signs
• Development of diarrhea (C. difficile risk with clindamycin) 2

Prosthetic Joint Infection Concerns

This is a critical distinction. If this represents early prosthetic joint infection (PJI) rather than superficial SSI:

• Debridement and retention strategy may be appropriate if within 30 days of implantation AND symptoms <3 weeks duration 3
• Would require 2-6 weeks IV antibiotics plus rifampin, followed by 3 months total oral therapy for hip 4, 3
• Orthopedic surgery consultation is mandatory if PJI suspected 3

Red flags for deep/prosthetic infection:

• Persistent fever or systemic symptoms
• Wound drainage despite antibiotics
• Increasing pain in the joint
• Elevated inflammatory markers (ESR, CRP)

Local Wound Management

Essential adjunctive measures:

• Keep pannus elevated and dry
• Use moisture-wicking dressings
• Consider skin barrier products
• Address obesity and skin fold management 1
• Daily wound inspection and dressing changes

Common Pitfalls to Avoid

1. Don't assume superficial infection without examining the wound - Deep infection can present with deceptively mild external findings 1
2. Don't continue antibiotics indefinitely without reassessment - If no improvement after 3-4 additional days, surgical evaluation is needed
3. Don't ignore C. difficile risk - Clindamycin carries significant CDAD risk; monitor for diarrhea 2
4. Don't miss prosthetic joint infection - Early PJI requires aggressive surgical and prolonged antibiotic management

If clinical improvement plateaus or worsens within 48-72 hours, obtain orthopedic surgery consultation immediately to rule out deep infection or PJI.